MYD88 and type 1 diabetes mellitus: These results are consistent with our findings showing that ablation of MyD88 signaling specifically in myeloid cells delayed the onset of T1D in NOD mice, and suggest that MyD88 likely acts also on other cell types to regulate autoimmunity in this model.